Omega Fund Management as of Sept. 30, 2016
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 11 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Juno Therapeutics | 28.2 | $37M | 1.2M | 30.01 | |
| Paratek Pharmaceuticals | 25.8 | $34M | 2.6M | 13.01 | |
| Egalet | 16.8 | $22M | 2.9M | 7.61 | |
| Fibrogen (FGEN) | 13.0 | $17M | 822k | 20.70 | |
| Nabriva Therapeutics | 6.2 | $8.1M | 1.1M | 7.05 | |
| Essa Pharma | 3.6 | $4.7M | 1.7M | 2.75 | |
| Pieris Pharmaceuticals | 2.6 | $3.4M | 1.8M | 1.83 | |
| Proteon Therapeutics | 1.8 | $2.3M | 250k | 9.33 | |
| Dicerna Pharmaceuticals | 1.0 | $1.3M | 224k | 5.88 | |
| Editas Medicine (EDIT) | 0.7 | $892k | 66k | 13.48 | |
| Cymabay Therapeutics | 0.5 | $585k | 302k | 1.94 |
